Free Trial

aTyr Pharma (ATYR) Earnings Date, Estimates & Call Transcripts

aTyr Pharma logo
$0.84 0.00 (-0.08%)
Closing price 04:00 PM Eastern
Extended Trading
$0.84 0.00 (-0.26%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

aTyr Pharma Earnings Summary

aTyr Pharma posted Q4 2025 earnings on March 5, 2026, reporting an EPS of -$0.14, which topped analysts' consensus estimates of -$0.18 by $0.04. With a trailing EPS of -$0.79, aTyr Pharma's earnings are expected to grow next year, from ($0.59) to ($0.39) per share.

Upcoming
Earnings Date
May. 6Before Market OpensEstimated
Consensus EPS
(Mar. 5)
-$0.18
Actual EPS
(Mar. 5)
-$0.14 Beat By $0.04

Q4 2025 Earnings Resources

ATYR Upcoming Earnings

aTyr Pharma's Q1 2026 earnings is estimated for Wednesday, May 6, 2026, based on past reporting schedules

Get aTyr Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on aTyr Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ATYR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATYR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

aTyr Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.15-$0.08-$0.12
Q2 20262-$0.16-$0.05-$0.11
Q3 20262-$0.18-$0.05-$0.12
Q4 20262-$0.19-$0.05-$0.12

aTyr Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2026
(Estimated)
--------
3/5/2026Q4 2025-$0.18-$0.14+$0.04-$0.14$0.02M-
11/6/2025Q3 2025-$0.20-$0.26 -$0.06-$0.26$0.91M$0.19M
8/7/2025Q2 2025-$0.18-$0.22 -$0.04-$0.22--
5/7/2025Q1 2025-$0.19-$0.17+$0.02-$0.17--
3/13/2025Q4 2024-$0.23-$0.18+$0.05-$0.18$0.02M-
11/7/2024--$0.22-$0.23 -$0.01-$0.23$0.13M-
8/13/2024Q2 2024-$0.24-$0.23+$0.01-$0.23$0.12M-

Data powered by Fiscal.ai.

aTyr Pharma Earnings - Frequently Asked Questions

aTyr Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 6th, 2026 based off last year's report dates. Learn more on ATYR's earnings history.

In the previous quarter, aTyr Pharma (NASDAQ:ATYR) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.18) by $0.04. Learn more on analysts' earnings estimate vs. ATYR's actual earnings.

aTyr Pharma's earnings report can be found in their filing with the SEC.
View SEC filing

aTyr Pharma (NASDAQ:ATYR) has a recorded annual revenue of $190,000.00.

aTyr Pharma (NASDAQ:ATYR) has a recorded net income of -$74.12 million. ATYR has generated -$0.79 earnings per share over the last four quarters.

aTyr Pharma's earnings are expected to grow from ($0.59) per share to ($0.39) per share in the next year.


This page (NASDAQ:ATYR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners